Healthcare corporate venturing is becoming a game of two parts – having long been totally dominated by investment in life sciences, a new form of health-related information technology investing is emerging. To see our most influential table in the sector, click here.

There is increased concern about how difficult it is to  secure a blockbuster drug for pharmaceutical companies, which has traditionally been, and remains by far, the biggest…